A song of hope dubbed ‘At the mention of your name’ has been released to commemorate the 17th global observance of World Lupus Day in Accra.
“The song is dedicated to all lupus warriors around the world. It is also dedicated to all those battling with autoimmune diseases, Covid-19 infections and different kinds of sicknesses,” said Emma Wilhelmina Halm Danso, Executive Director of Oyemam Autoimmune Foundation (OYEMAM).
Lupus is a chronic autoimmune disease that affect at least 5 million people worldwide.
Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.